Zilbrysq 16.6 mg (Zilucoplan (Zilucoplan Sodium) SOLUTION) 16.6 MG

ZILBRYSQ 16.6 MG is a subcutaneous solution containing Zilucoplan (Zilucoplan Sodium). This medication is used for managing certain autoimmune conditions. Learn more about its uses and effects.

Strength

16.6 MG

Manufacturer / TM Owner

UCB CANADA INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

ZILBRYSQ 16.6 MG is primarily used for the treatment of autoimmune disorders. Zilucoplan, the active ingredient, works by modulating the immune system to reduce inflammation and other symptoms associated with these conditions. Patients often wonder, 'What is ZILBRYSQ used for?' It is typically prescribed for conditions where immune system regulation is beneficial.

Side Effects

Common effects of ZILBRYSQ 16.6 MG may include localized reactions at the injection site, such as redness or swelling. Some users may also experience general side effects like fatigue or mild gastrointestinal discomfort. These effects vary among individuals and are not exhaustive.

Precautions & Warnings

ZILBRYSQ 16.6 MG should be handled with care, ensuring proper storage and administration techniques. It is important to follow healthcare provider instructions for subcutaneous use. Always check for any signs of allergic reactions and consult a healthcare professional if concerns arise.

Avoid Interactions

ZILBRYSQ 16.6 MG may interact with other medications, particularly those that affect the immune system. Alcohol and certain supplements could also influence its effects. It is advisable to discuss all current medications with a healthcare provider to avoid potential interactions.

Frequently Asked Questions

ZILBRYSQ 16.6 MG is used for managing certain autoimmune conditions by modulating the immune system.

ZILBRYSQ 16.6 MG is administered subcutaneously, typically by injection.

Common side effects may include localized reactions at the injection site and general discomfort.

Potential interactions with other medications should be discussed with a healthcare provider.

ZILBRYSQ 16.6 MG should be stored as per the instructions provided, typically in a cool, dry place.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.